Psychedelic medicine biotech firm MindMed is conducting a clinical trial in Switzerland that will evaluate the use of MDMA and LSD in combination to determine whether the former can increase positive subject drug effects and reduce negative emotions and anxiety that are sometimes associated with the latter.
Toronto-based Awakn Life Sciences and contract research organization PRA Health Sciences have announced plans to study MDMA-assisted psychotherapy as a treatment for patients with alcohol use disorder.
UFC, the top mixed martial arts promotion in the United States, has approached researchers at Johns Hopkins University to explore the potential use of psychedelics in treatment for its fighters, according to media reports.
Following the announcement of new executives and plans for a translational research program on the use of psychedelics in the treatment of physical and psychological pain, Mind Cure is acquiring an ownership interest in psychedelic-assisted therapy provider ATMA Journey Centers.
The use of psychedelics in psychotherapy can help patients go beyond ameliorating symptoms and confront their root causes of depression, Andrew D. Penn, RN, MS, NP, CNS, APRN-BC, and Charles Raison, MD, said at a session at the Psych Congress 2020…
The US Food and Drug Administration (FDA) recently granted Usona Institute, Madison, Wisconsin, the Breakthrough Therapy designation for psilocybin in the treatment of patients with major depressive disorder (MDD).
SAN DIEGO—Psilocybin-assisted psychotherapy appears to have a beneficial and lasting effect on patient mood, but possible approval of the treatment remains some time away, a researcher said at Psych Congress 2019.
SAN FRANCISCO—Alcohol use and cravings decreased in participants with higher scores on the Mystical Experience Questionnaire in a controlled study assessing psilocybin-assisted psychotherapy for alcohol dependence, according to preliminary results presented at the American Psychiatric Association’s annual meeting.